Myocardial tissue deformation is reduced in subjects with coronary microvascular dysfunction but not rescued by treatment with ranolazine.

Item

http://www.wikidata.org/entity/Q48582664

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Myocardial tissue deformation ...... by treatment with ranolazine.

@en

Myocardial tissue deformation ...... by treatment with ranolazine.

@nl

type

Item

label

Myocardial tissue deformation ...... by treatment with ranolazine.

@en

Myocardial tissue deformation ...... by treatment with ranolazine.

@nl

prefLabel

Myocardial tissue deformation ...... by treatment with ranolazine.

@en

Myocardial tissue deformation ...... by treatment with ranolazine.

@nl

P1476

Myocardial tissue deformation ...... by treatment with ranolazine.

@en

P2093

Chrisandra Shufelt

http://www.w3.org/2001/XMLSchema#string

Daniel S Berman

http://www.w3.org/2001/XMLSchema#string

Debiao Li

http://www.w3.org/2001/XMLSchema#string

Eileen M Handberg

http://www.w3.org/2001/XMLSchema#string

Galen Cook-Wiens

http://www.w3.org/2001/XMLSchema#string

Jaime L Shaw

http://www.w3.org/2001/XMLSchema#string

Janet Wei

http://www.w3.org/2001/XMLSchema#string

Louise E J Thomson

http://www.w3.org/2001/XMLSchema#string

Puja K Mehta

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve

Ranolazine improves cardiac diastolic dysfunction through modulation of myofilament calcium sensitivity

Heart disease and stroke statistics--2014 update: a report from the American Heart Association

Diastolic dysfunction in women with signs and symptoms of ischemia in the absence of obstructive coronary artery disease: a hypothesis-generating study

Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study.

Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.

Reference left atrial dimensions and volumes by steady state free precession cardiovascular magnetic resonance.

Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.

Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina.

The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health--National Heart, Lung, and Blood Institute--sponsored Women's Ischemia Syndrome Evaluation.

P304

300-306

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CLC.22660

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-12-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28004395

http://www.w3.org/2001/XMLSchema#string

P932

5436931

http://www.w3.org/2001/XMLSchema#string